# Peripheral Angioplasty Market > Peripheral Angioplasty Market Research Report Information By Product (Balloon Catheters, Stents, and Guidewires), By End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Centers) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.9% - **2024:** $ 4.21 Billion - **2025:** $ 4.54 Billion - **2035:** $ 9.71 Billion - **Key Players:** Medtronic(US), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cordis Corporation (US), Cook Medical (US), AngioDynamics (US), Asahi Intecc Co., Ltd. (JP) **Report ID:** MRFR/HC/14606-HCR · **Pages:** 128 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/peripheral-angioplasty-market-16133 --- ## Market Summary ## **Peripheral Angioplasty Market Overview** As per MRFR analysis, the Peripheral Angioplasty Market Size was estimated at 4.21 (USD Billion) in 2024. The Peripheral Angioplasty Market Industry is expected to grow from 4.54 (USD Billion) in 2025 to 9.00 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.90% during the forecast period (2025 - 2034). Increased obesity, diabetes, sedentary lifestyles, and aging populations are the key market drivers boosting the expansion of the market. Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Angioplasty Market Trends** Market CAGR for Peripheral Angioplasty is being driven by the Growing Number of Elderly People. Narrowed arteries in peripheral arterial disease (PAD) limit blood flow to the limbs. PAD is a common circulatory condition. The arteries that bring blood from the heart to the brain, arms, kidneys, and stomach are occasionally affected by PAD, but primarily the arteries in the legs are affected. It is brought on by fat deposits (plaques) in the artery walls, which lower blood flow to the head, limbs, and organs. Additionally, peripheral angioplasty treatments are in high demand to open blocked or narrowed arteries and restore blood flow because of the rising prevalence of peripheral artery disease (PAD), which includes atherosclerosis and is more common in the elderly population. Peripheral angioplasty operations are becoming more successful and effective because to ongoing improvements in angioplasty techniques, including the creation of drug-coated balloons, atherectomy devices, and enhanced stent technology. Peripheral angioplasty has become more popular since patients and medical professionals find that minimally invasive procedures have fewer side effects, quicker recovery periods, and fewer hospital stays than standard surgeries. The prevalence of peripheral arterial disorders is higher in the aging population. Peripheral angioplasty is one intervention that is becoming more and more necessary as this demographic keeps growing. The incidence of peripheral arterial disorders is influenced by lifestyle-related factors such obesity, diabetes, and hypertension. Peripheral angioplasty is one intervention that is necessary to treat associated arterial blockages and stenosis. Peripheral angioplasty market expansion is aided by government programs that support enhanced access to healthcare, better healthcare infrastructure, and investments in cutting-edge medical technologies. Peripheral angioplasty procedures are increasingly accessible to patients due to favorable reimbursement regulations that incentivize healthcare professionals to offer them. Peripheral angioplasty device innovation is fueled by competition among medical device makers, which leads to the creation of more sophisticated and potent devices and more treatment alternatives for patients. For instance, peripheral artery disease (PAD) affects over 6.5 million adults in North America who are 40 years of age and older. This information comes from the Centers for Disease Control and Prevention (CDC). Some of the main high-risk factors that lead to an increase in new PAD cases ly are smoking, coronary artery disease diabetes, high blood pressure, and cholesterol. Thus, result in driving the Peripheral Angioplasty market revenue. ## **Peripheral Angioplasty Market Segment Insights** ### **Peripheral Angioplasty Product Insights** The  Peripheral Angioplasty market segmentation, based on Product includes Balloon Catheters, Stents, and Guidewires. The balloon catheters segment dominated the market. A key element of peripheral angioplasty treatments are balloon catheters. In order to restore blood flow to the afflicted location, they are utilized to widen constricted or blocked blood vessels in the peripheral arteries. Balloon catheters are a vital instrument in the field of peripheral angioplasty because of their efficacy in producing vessel dilatation. ### **Peripheral Angioplasty End User Insights** The  Peripheral Angioplasty market segmentation, based on End User, includes Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Centers. The hospitals category generated the most income. Hospitals have the equipment and facilities needed to carry out [peripheral angioplasty treatments](../../../reports/peripheral-angioplasty-market-16133). They have dedicated catheterization labs with cutting-edge imaging tools like fluoroscopy and angiography, which help with accurate visualization and guiding during the process. Peripheral angioplasty services are made available to patients by institutions having these cutting-edge treatment facilities accessible to them. **Figure1: Peripheral Angioplasty Market, by End User, 2024 & 2032(USD Billion)** **** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ### **Peripheral Angioplasty Regional Insights** By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Peripheral Angioplasty market area will dominate this market. This is because the market is driven by factors including rising rates of cardiovascular illnesses and an aging population. Additionally, the market is growing as a result of the rising number of cardiovascular disease cases in the United States. Moreover, the bulk of the significant industry participants are present in North America. Further, the major countries studied in the market report are The US, German, France, the UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil. **Figure2: PERIPHERAL ANGIOPLASTY MARKET SHARE BY REGION 2023 (USD Billion)** **** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review Europe Peripheral Angioplasty market has the second-largest portion of the market. This is due to an increase in the aging population in the region. Further, the German Peripheral Angioplasty market had the biggest market share, and the UK Peripheral Angioplasty market was the European market with the quickest rate of growth. The Asia-Pacific Peripheral Angioplasty Market is anticipated to expand between 2024 and 2032 at the quickest CAGR. This is due to the growing prevalence of diabetes, which raises the risk of peripheral vascular diseases. Moreover, China’s Peripheral Angioplasty market had the biggest market share, and the Indian Peripheral Angioplasty market was the Asia-Pacific region's fastest-growing market. **Peripheral Angioplasty Key Market Players& Competitive Insights** Leading market players are putting a lot of money on R&D to expand their product lines, which will drive the peripheral angioplasty market's expansion. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, Peripheral Angioplasty industry must provide reasonably priced goods. Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the  Peripheral Angioplasty industry to help customers and expand the market segment. In recent years, the Peripheral Angioplasty industry has provided some of the biggest benefits to medicine. Major players in the Peripheral Angioplasty market, including Edwards Lifesciences Corporation, B. Braun Melsungen AG, Cook Medical, Johnson & Johnson, Terumo Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation, and others, are engaging in research and development activities in an effort to boost market demand. Boston Scientific Corporation ("BSC") is a worldwide biomedical/biotechnology engineering company that produces medical devices for use in a variety of interventional medical disciplines, such as interventional cardiology and radiology. On June 29, 1979, Boston Scientific was established in Watertown, Massachusetts, forty-four years ago, as a holding company for Medi-Tech, Inc., a medical goods company, with the goal of positioning the latter for expansion into the field of interventional medicine. Itzhak Bentov, a Czech who immigrated to Israel and later the US, was the creator of Medi-Tech. In January 2021, Boston declared that it will pay up to $1.2 billion to acquire Minneapolis-based Preventice Solutions, Inc. and its suite of mobile heart health solutions. Abbott Laboratories is a worldwide medical equipment and healthcare firm. In addition to selling medical equipment, diagnostics, branded generic medications, and nutritional goods, the company was established in 1888 by Chicago physician Wallace Calvin Abbott to develop well-known drugs. In 2013, it divided into AbbVie and separated its research-based pharmaceutical division. MitraClip, Glucerna, Ensure, ZonePerfect, FreeStyle Libre, i-STAT, Similac, Pedialyte, and BinaxNOW are among the products made by Abbott. In January 2022, Abbott unveiled Lingo, a set of consumer biowearable sensors that gathers biological data to enhance diet and exercise plans. **Key Companies in the Peripheral Angioplasty market include** **Peripheral Angioplasty Industry Developments** **June 2022:** Cardio Flow, Inc. is a medical device business that produces less invasive peripheral vascular gadgets for peripheral artery disease treatment (PAD). The company recently announced that the FreedomFlow Peripheral Guidewire it makes has received FDA approval. **January 2022: **Cook Medical was awarded breakthrough device designation by the FDA in the United States for a unique drug-eluting below-the-knee (BTK) stent. The purpose of this novel stent is to treat patients with chronic ischemia that poses a hazard to their limbs. **May 2022**:Medtronic stated that the USA Food and Drug Administration (FDA) has approved the IN. PACTTM paclitaxel-coated percutaneous transluminal angioplasty device, also known as the Balloon Catheter. ## **Peripheral Angioplasty Market Segmentation** ### **Peripheral Angioplasty Product Outlook** ### **Peripheral Angioplasty End User Outlook** ### **Peripheral Angioplasty Regional Outlook** ## Market Drivers ### Rising Geriatric Population The rising geriatric population is a significant driver of the Peripheral Angioplasty Market. As individuals age, they are more susceptible to cardiovascular diseases, including PAD. The World Health Organization projects that the number of people aged 60 years and older will double from 12% to 22% of the global population by 2050. This demographic shift is likely to increase the demand for angioplasty procedures as older adults seek effective treatments for their vascular conditions. Consequently, the Peripheral Angioplasty Market is expected to expand in response to the growing needs of this population, highlighting the importance of tailored healthcare solutions. ### Supportive Regulatory Frameworks Supportive regulatory frameworks are playing a crucial role in shaping the Peripheral Angioplasty Market. Regulatory bodies are increasingly approving new devices and technologies that enhance the safety and efficacy of angioplasty procedures. This regulatory support fosters innovation and encourages manufacturers to invest in research and development. As a result, the market is likely to see a surge in the introduction of advanced angioplasty solutions. Furthermore, streamlined approval processes can expedite the availability of these innovations to healthcare providers, thereby enhancing patient care and driving growth in the Peripheral Angioplasty Market. ### Rising Prevalence of Peripheral Artery Disease The increasing incidence of peripheral artery disease (PAD) is a primary driver for the Peripheral Angioplasty Market. As populations age, the prevalence of conditions such as diabetes and hypertension rises, leading to higher rates of PAD. According to recent estimates, PAD affects approximately 8 to 12 million individuals in the United States alone. This growing patient population necessitates effective treatment options, including angioplasty procedures. The Peripheral Angioplasty Market is likely to expand as healthcare providers seek to address the needs of these patients, offering innovative solutions to improve vascular health and reduce complications associated with PAD. ### Technological Innovations in Angioplasty Devices Technological advancements in angioplasty devices are significantly influencing the Peripheral Angioplasty Market. Innovations such as drug-eluting balloons and bioresorbable stents have enhanced the efficacy and safety of angioplasty procedures. These devices are designed to reduce restenosis rates and improve patient outcomes. The market for these advanced devices is projected to grow, with estimates suggesting a compound annual growth rate of over 6% in the coming years. As healthcare providers increasingly adopt these technologies, the Peripheral Angioplasty Market is expected to witness substantial growth, driven by the demand for improved treatment options. ### Increasing Awareness and Education on Vascular Health The growing awareness and education surrounding vascular health are contributing to the expansion of the Peripheral Angioplasty Market. Public health campaigns and educational initiatives aimed at promoting awareness of PAD and its risk factors are encouraging individuals to seek medical attention sooner. This proactive approach leads to earlier diagnosis and treatment, including angioplasty procedures. As more patients become informed about their vascular health, the demand for effective interventions is likely to rise, thereby propelling the Peripheral Angioplasty Market forward. Healthcare providers are responding by enhancing their services to meet this increasing demand. ## Future Outlook The Peripheral Angioplasty Market is projected to grow at a 7.9% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of biodegradable stents for enhanced patient outcomes. - - Expansion of telehealth services for remote patient monitoring post-procedure. - Investment in AI-driven analytics for personalized treatment plans. By 2035, the Peripheral Angioplasty Market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product: Balloon Catheters (Largest) vs. Stents (Fastest-Growing) In the Peripheral Angioplasty Market, Balloon Catheters hold the largest market share, attributed to their fundamental role in angioplasty procedures. This segment is well-established, with a broad adoption rate among healthcare professionals due to their effectiveness in dilating narrowed arteries. On the other hand, Stents are rapidly gaining traction, showcasing significant growth due to technological advancements that enhance patient outcomes and the increasing prevalence of peripheral artery diseases. The growing awareness and acceptance of stenting among patients and clinicians are driving this emerging segment. Balloon Catheters (Dominant) vs. Stents (Emerging) Balloon Catheters are considered the dominant product in the Peripheral Angioplasty Market due to their reliability and essential role during angioplasty. They are primarily used for expanding narrowed arteries and play a critical role in restoring blood flow. Meanwhile, Stents are an emerging technology with significant potential for growth. Recent advancements in stent design and materials, such as drug-eluting stents, are making them increasingly popular for their ability to prevent restenosis. Both segments are vital for improving patient outcomes, with [Balloon](https://www.marketresearchfuture.com/reports/balloon-infuser-market-37061)Catheters leading the market and Stents rapidly expanding their presence. ### By End User: Hospitals (Largest) vs. Cardiac Catheterization Centers (Fastest-Growing) The Peripheral Angioplasty Market is largely dominated by hospitals, which account for the majority of procedures conducted in this sector. This preference is influenced by hospitals having more advanced facilities and specialist personnel capable of managing complex angioplasty cases. Ambulatory surgical centers, while significant, hold a smaller market share owing to their limited capacity for comprehensive patient care compared to hospitals. Cardiac catheterization centers present a notable segment as they are specifically designed for cardiovascular procedures, which is key in enhancing the quality of peripheral angioplasty treatments. Hospitals (Dominant) vs. Cardiac Catheterization Centers (Emerging) Hospitals are the predominant end-user segment in the Peripheral Angioplasty Market, primarily due to their extensive resources, including advanced medical technologies and experienced specialists. They provide a broad range of services, which not only attract a larger patient base but also ensure safer and more comprehensive treatment options. In contrast, cardiac catheterization centers are rapidly emerging, specializing solely in cardiovascular conditions. Their growth is driven by the increasing prevalence of peripheral vascular diseases and technological advancements that allow for safer, faster procedures. As these centers develop, their unique positioning may potentially shift patient preferences, leading to a competitive but complementary market relationship. ## Regional Market Share Analysis ### North America : Market Leader in Innovation North America is the largest market for peripheral angioplasty, accounting for approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of peripheral artery disease, and favorable reimbursement policies. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing patient outcomes. The United States is the primary contributor, with significant investments from key players such as Medtronic, Boston Scientific, and Abbott Laboratories. The competitive landscape is characterized by continuous product development and strategic partnerships. The presence of established companies ensures a robust supply chain and access to cutting-edge technologies, solidifying North America's position as a leader in the peripheral angioplasty market. ### Europe : Emerging Market with Growth Potential Europe is witnessing significant growth in the peripheral angioplasty market, holding approximately 30% of the global share. The region benefits from an aging population, increasing awareness of cardiovascular diseases, and advancements in medical technology. Regulatory frameworks, such as the Medical Device Regulation (MDR), are enhancing safety and efficacy standards, driving market growth and innovation. Germany, France, and the UK are the leading countries in this market, with a strong presence of key players like B. Braun Melsungen AG and Terumo Corporation. The competitive landscape is marked by collaborations and mergers aimed at expanding product portfolios. The focus on minimally invasive procedures and improved patient outcomes is shaping the future of peripheral angioplasty in Europe. ### Asia-Pacific : Rapid Growth and Investment The Asia-Pacific region is emerging as a significant player in the peripheral angioplasty market, accounting for about 20% of the global share. Factors such as rising disposable incomes, increasing healthcare expenditure, and a growing prevalence of lifestyle-related diseases are driving demand. Government initiatives aimed at improving healthcare access and infrastructure are also contributing to market growth. Countries like Japan, China, and India are at the forefront, with a mix of local and international players like Asahi Intecc Co., Ltd. and Cook Medical. The competitive landscape is evolving, with a focus on innovation and affordability. The region's diverse market dynamics present both challenges and opportunities for growth in the peripheral angioplasty sector. ### Middle East and Africa : Untapped Market with Potential The Middle East and Africa region is gradually developing in the peripheral angioplasty market, holding around 5% of the global share. The growth is driven by increasing awareness of cardiovascular diseases, improving healthcare infrastructure, and rising investments in medical technology. Government initiatives to enhance healthcare access are also playing a crucial role in market expansion. Countries like South Africa and the UAE are leading the way, with a growing presence of international players. The competitive landscape is characterized by a mix of local and global companies, focusing on affordability and accessibility. As healthcare systems evolve, the potential for growth in the peripheral angioplasty market in this region is significant, presenting opportunities for investment and innovation. ## Competitive Benchmarking Leading market players are putting a lot of money on R&D to expand their product lines, which will drive the peripheral angioplasty market's expansion. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, Peripheral Angioplasty industry must provide reasonably priced goods.Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the  Peripheral Angioplasty industry to help customers and expand the market segment. In recent years, the Peripheral Angioplasty industry has provided some of the biggest benefits to medicine. Major players in the Peripheral Angioplasty Market, including Edwards Lifesciences Corporation, B. Braun Melsungen AG, Cook Medical, Johnson & Johnson, Terumo Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation, and others, are engaging in research and development activities in an effort to boost market demand.Boston Scientific Corporation ("BSC") is a worldwide biomedical/biotechnology engineering company that produces medical devices for use in a variety of interventional medical disciplines, such as interventional cardiology and radiology. On June 29, 1979, Boston Scientific was established in Watertown, Massachusetts, forty-four years ago, as a holding company for Medi-Tech, Inc., a medical goods company, with the goal of positioning the latter for expansion into the field of interventional medicine. Itzhak Bentov, a Czech who immigrated to Israel and later the US, was the creator of Medi-Tech. In January Boston declared that it will pay up to $1.2 billion to acquire Minneapolis-based Preventice Solutions, Inc. and its suite of mobile heart health solutions.Abbott Laboratories is a worldwide medical equipment and healthcare firm. In addition to selling medical equipment, diagnostics, branded generic medications, and nutritional goods, the company was established in 1888 by Chicago physician Wallace Calvin Abbott to develop well-known drugs. In 2013, it divided into AbbVie and separated its research-based pharmaceutical division. MitraClip, Glucerna, Ensure, ZonePerfect, FreeStyle Libre, i-STAT, Similac, Pedialyte, and BinaxNOW are among the products made by Abbott. In January Abbott unveiled Lingo, a set of consumer biowearable sensors that gathers biological data to enhance diet and exercise plans. ## Recent News & Developments **June 2022:** Cardio Flow, Inc. is a medical device business that produces less invasive peripheral vascular gadgets for peripheral artery disease treatment (PAD). The company recently announced that the FreedomFlow Peripheral Guidewire it makes has received FDA approval. **January 2022: **Cook Medical was awarded breakthrough device designation by the FDA in the United States for a unique drug-eluting below-the-knee (BTK) stent. The purpose of this novel stent is to treat patients with chronic ischemia that poses a hazard to their limbs. **May 2022**:Medtronic stated that the USA Food and Drug Administration (FDA) has approved the IN. PACTTM paclitaxel-coated percutaneous transluminal angioplasty device, also known as the Balloon Catheter. ## Report Scope | MARKET SIZE 2024 | 4.208(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 4.541(USD Billion) | | MARKET SIZE 2035 | 9.714(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.9% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cordis Corporation (US), Cook Medical (US), AngioDynamics (US), Asahi Intecc Co., Ltd. (JP) | | Segments Covered | Product, End User, Region | | Key Market Opportunities | Integration of advanced imaging technologies enhances precision in the Peripheral Angioplasty Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive competitive dynamics in the Peripheral Angioplasty Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Peripheral Angioplasty Market by 2035?** A: The Peripheral Angioplasty Market is projected to reach a valuation of 9.714 USD Billion by 2035. **Q: What was the market valuation of the Peripheral Angioplasty Market in 2024?** A: In 2024, the Peripheral Angioplasty Market was valued at 4.208 USD Billion. **Q: What is the expected CAGR for the Peripheral Angioplasty Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Peripheral Angioplasty Market during the forecast period 2025 - 2035 is 7.9%. **Q: Which product segment had the highest valuation in 2024 within the Peripheral Angioplasty Market?** A: In 2024, the Stents segment had the highest valuation at 1.6824 USD Billion. **Q: What is the projected valuation for Balloon Catheters by 2035?** A: The projected valuation for Balloon Catheters is expected to reach 2.8836 USD Billion by 2035. **Q: Which end user segment is anticipated to grow the most by 2035?** A: The Hospitals segment is anticipated to grow the most, reaching a projected valuation of 4.1 USD Billion by 2035. **Q: Who are the key players in the Peripheral Angioplasty Market?** A: Key players in the Peripheral Angioplasty Market include Medtronic, Boston Scientific, and Abbott Laboratories, among others. **Q: What was the valuation of the Guidewires segment in 2024?** A: The Guidewires segment was valued at 1.2632 USD Billion in 2024. **Q: How does the projected growth of Ambulatory Surgical Centers compare to other end user segments by 2035?** A: By 2035, Ambulatory Surgical Centers are projected to reach 2.8 USD Billion, indicating substantial growth compared to their 2024 valuation. **Q: What is the expected market trend for the Peripheral Angioplasty Market in the coming years?** A: The Peripheral Angioplasty Market is expected to experience robust growth, driven by advancements in technology and increasing demand for minimally invasive procedures. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/peripheral-angioplasty-market-16133*